Lentiviral vector-mediated gene transfer and uses thereof

Details Lentiviral vector-mediated gene transfer and uses thereof Lentiviral vector-mediated gene transfer and uses thereof

2006-10-17

2006-10-17

Kaushal, Sumesh (Department: 1636)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093100, C424S093600, C435S069100, C435S320100, C435S325000, C435S455000, C514S04400A

Reexamination Certificate

active

07122181

ABSTRACT:
The present invention provides lentiviral vectors that are useful in human gene therapy for inherited or acquired proliferative ocular disease. It furnishes methods to exploit the ability of lentiviral vectors to transduce both mitotically active and inactive cells so that eye diseases may be treated.

REFERENCES:
patent: 5969120 (1999-10-01), Fung
patent: 6004798 (1999-12-01), Anderson et al.
patent: 2002/0114783 (2002-08-01), Appukuttan et al.
patent: 2002/0194630 (2002-12-01), Manning, Jr. et al.
patent: 2003/0045498 (2003-03-01), Kovesdi et al.
patent: 2003/0087859 (2003-05-01), Kochanek et al.
patent: WO 02/24234 (2002-03-01), None
patent: WO 02/49677 (2002-06-01), None
Juengst BMJ, 326:1410-11, 2003.
Brown et al Blood 100(4) :133-1140, 2002.
Rosenberg et al, Science 287:1751, 2000.
Friedmann, Science 287(5461):2163-5, 2000.
Touchette, Nat. Med. 2(1) 7-8, 1996.
Hamdi et al, Frontiers in Bioscience 8:e305-314, 2003.
Borras, Exp. Eye Res. 76:643-652, 2003.
McFarland et al Expert Opin. Biol. Ther 4(7):1053-1058, 2004.
Murata, T. et al.The Possibility of Gene Therapy for the Treatment of Choroidal Neovascularization: Ophthalmology,Jul. 2000, vol. 107, No. 7, pp. 1364-1373.
Sakamoto, T. et al.Inhibition of Experimental Proliferative Vitretinopathy by Retroviral Vector-mediated Transfer of Suicide Gene: Ophthalmology,Oct. 1995, vol. 102, No. 10, pp. 1417-1424.
Acland et al., “Gene therapy restores vision in a canine model of childhood blindness,”Nature Genetics,28:92-95, 2001.
Akimoto et al., “Growth inhibition of cultured human tenon's fibroblastic cells by targeting the E2F transcription factor,”Exp. Eye Res.,67:395-401, 1998.
Ali et al., “Gene transfer into the mouse retina mediated by an adeno-associated viral vector,”Human Molecular Genetics,5(5):591-594, 1996.
Audo et al., “p21 and p35 gene therapy in a mouse model of retinoblastoma,” ARVO Annual Meeting, vol. 2003, Abstract No. 1585, May 5, 2003.
Auricchio et al., “Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents,”Molecular Therapy,6(4):490-494, 2002.
Benihoud et al., “Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin α,”Journal of Virology,72(12):9514-9525, 1998.
Chen et al., “Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells,”Cell Growth and Differentiation,3:119-125, 1992.
Cheon et al., “Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cells proliferative activity,”BJU International,85:759-766, 2000.
Claudio et al., “Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty,”Circulation Research,85:1032-1039, 1999.
Dejneka and Bennett, “Gene therapy and retinitis pigmentosa: advances and future challenges,”BioEssays,23:662-668, 2001.
Dong et al., “Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β,”Cancer Res.,59:872-879, 1999.
Farrar et al., “On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention,”The EMBO J.,21(5):857-864, 2002.
Galileo et al., “Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf mouse using a lentiviral vector,”Current Eye Research,18(2):135-142, 1999.
Gasperini et al., “Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils,”J. Immunol.,162:4928-4937, 1999.
Green et al., “Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18,”Molecular Therapy,3(4):507-515, 2001.
Harvey et al., “Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors,”Molecular and Cellular Neuroscience,21:141-157, 2002.
Holmgren et al., “p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma,”Oncogene,17:819-824, 1998.
Ikuno et al., “Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor,”Investigative Ophthalmology&Visual Science,41(10):3107-3116, 2000.
Jomary et al., “Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration,”Gene Therapy,4:683-690, 1997.
Kagawa et al., “Overexpression of the p21sdilgene induced senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer,”Cell Death and Differentiation,6:765-772, 1999.
Kobayashi et al., “Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes,”Gene Therapy,7:527-533, 2000.
Kreppel et al., “Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector,”Investigative Ophthalmology&Visual Science,43(6):1965-1970, 2002.
Loewen et al., “Genetic modification of human trabecular meshwork with lentiviral vectors,”Human Gene Therapy,12:2109-2119, 2001.
Lotery et al., “Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors,”Human Gene Therapy,13:689-696, 2002.
Miyoshi et al., “Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector,”Proc. Natl. Acad. Sci., USA,94:10319-10323, 1997.
Mori et al., “AAA-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization,”Investigative Ophthalmology&Visual Science,43(6):1994-2000, 2002.
Riley et al., “Prospects for tumor suppressor gene therapy: RB as an example,”Tumor Suppressing Viruses, Genes and Drugs,Maruta Publisher: Academic Press, San Diego, CA, 97-122, 2002.
Sakamoto et al., “Gene targeting to the retina,”Advanced Drug Delivery Reviews,52:93-102, 2001.
Schechner et al., “In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse,”Proc. Natl. Acad. Sci., USA,97(16):9191-9196, 2000.
Scherr et al., “Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras,”Gene Therapy,5:1227-1234, 1998.
Schwerzenberger, “IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines,”The Journal of Immunology,161:6383-6389, 1998.
Shirakawa et al., “p53 adenoviral vector (AD-CMV-p53 induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model,”The Journal of Gene Medicine,2:426-432, 2000.
Szekely et al., “RB-reconstituted human retinoblastoma cells form RB-positive intraocular and intracerebral but not subcutaneous tumors in scid mice,”Int. J. Cancer,61:683-691, 1995.
Takahashi et al., “Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer,”Journal of Virology,73(9):7812-7816, 1999.
Wang et al., “Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector,”Gene Therapy,7:169-200, 2000.
Wen et al., “Characterization of adenovirus p21 gene transfer, biodistribution, and immune response after local ocular delivery in New Zealand white rabbits,

Affiliated with

Also associated with

Rating

Lentiviral vector-mediated gene transfer and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lentiviral vector-mediated gene transfer and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lentiviral vector-mediated gene transfer and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3652007